1989
DOI: 10.1093/jnci/81.6.440
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Metastases of a Human Melanoma Xenograft by Monoclonal Antibody to the GD2/GD3 Gangliosides

Abstract: A human melanoma variant cell line was obtained from a lung metastasis that arose spontaneously after we inoculated melanoma cells sc into a nude mouse. In this model, IgG2a monoclonal antibody (MAb) ME 36.1 defining the GD2/GD3 gangliosides inhibited melanoma growth at the primary site and metastatic spread of the cells, whereas an IgG1 variant of MAb ME 36.1 inhibited lung metastasis formation only. Possible mechanisms of antitumor effects of MAb ME 36.1 are discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
40
0

Year Published

1990
1990
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 78 publications
(41 citation statements)
references
References 0 publications
1
40
0
Order By: Relevance
“…The facts that GD3 is highly expressed in melanomas in comparison with melanocytes, is exclusively expressed in the early developmental stage of the fetal brain (10), and is highly expressed in activated T lymphocytes and in T cell malignant tumor cells (12)(13)(14)(15) suggest that GD3 is involved in tumor phenotypes, such as enhanced proliferation and frequent metastasis. There have been a number of reports indicating that GD3 is associated with cell adhesion to the extracellular matrix (20), increased cell growth (17), and invasion activity (21). In fact, anti-GD3 antibodies appeared to suppress cultured melanoma growth (16,22), and GD3-lacking mutants of SK-MEL-28 showed markedly reduced cell proliferation (17), supporting its role in cell growth.…”
Section: Discussionmentioning
confidence: 98%
“…The facts that GD3 is highly expressed in melanomas in comparison with melanocytes, is exclusively expressed in the early developmental stage of the fetal brain (10), and is highly expressed in activated T lymphocytes and in T cell malignant tumor cells (12)(13)(14)(15) suggest that GD3 is involved in tumor phenotypes, such as enhanced proliferation and frequent metastasis. There have been a number of reports indicating that GD3 is associated with cell adhesion to the extracellular matrix (20), increased cell growth (17), and invasion activity (21). In fact, anti-GD3 antibodies appeared to suppress cultured melanoma growth (16,22), and GD3-lacking mutants of SK-MEL-28 showed markedly reduced cell proliferation (17), supporting its role in cell growth.…”
Section: Discussionmentioning
confidence: 98%
“…Neutrophils express several subtypes of FcRs capable of inducing ADCC, including FcγRI (CD64), FcγRIIa (CD32), FcγRIIIa (CD16a), and FcγRIIIb (CD16b) [336][337][338], whose surface expression is increased following G-CSF stimulation [338,339]. FcγRI was shown to mediate neutrophil ADCC activity against glioma, squamous cell and ovarian carcinoma cells [338].…”
Section: Antibody-dependent Cell-mediated Cytotoxicity (Adcc)mentioning
confidence: 99%
“…mRNA levels of MMP-2 were exceptionally high in some melanoma cell lines (WM239, WM793, WM852 and WM165), while in three other melanoma cell lines (G361, WM164, Bowes) MMP-2 was expressed at a level comparable to that of HT-1080 cells (Figure 3). Interestingly, the cell lines G361 and WM164, that were negative for both MMP-1 and -2 mRNAs, have been established from primary non-metastatic melanoma cell lines (Peebles et al, 1980;Iliopoulos et al, 1989). Cell lines expressing both MMP-1 and -2 (WM239, WM165, ML852) have been established from melanoma metastases (Herlyn et al, 1985a(Herlyn et al, , 1985b.…”
Section: Mt1-mmp and Mmp-2 Are Expressed By Cultured Melanoma Cellsmentioning
confidence: 99%